Australia
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 14.69 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
2 |
USD 459.88 M
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
3 |
USD 338.23 M
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
4 |
USD 114.39 M
|
June 30, 2024 | USD 2.01 | -0.68% |
|
Australia |
|
5 |
USD 103.36 M
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
6 |
USD 68.80 M
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
7 |
USD 58.79 M
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
8 |
USD 14.71 M
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
9 |
USD 7.67 M
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
10 |
USD 5.90 M
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
11 |
USD 4.58 M
|
June 30, 2024 | USD 3.66 | 3.57% |
|
Australia |
|
12 |
USD 3.27 M
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
13 |
USD 2.80 M
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
14 |
USD 2.68 M
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
15 |
USD 2.56 M
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
16 |
USD 1.54 M
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
17 |
USD 124.67 K
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
The Biotechnology company in Australia with the highest Revenue is CSL Limited (ASX: CSL.AX) at USD 14.69 B.
The Biotechnology company in Australia with the lowest Revenue is Opthea Limited (NasdaqGS: OPT) at USD 124.67 K.
The top 10 Biotechnology companies in Australia by Revenue are CSL Limited, Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, Nanosonics Limited, Trajan Group Holdings Limited, PolyNovo Limited, Clinuvel Pharmaceuticals Limited, PYC Therapeutics Limited, Clarity Pharmaceuticals Ltd and Mesoblast Limited.
The bottom 10 Biotechnology companies in Australia by Revenue are Opthea Limited, Kazia Therapeutics Limited, Immutep Limited, Alterity Therapeutics Limited, Anteris Technologies Ltd, Immuron Limited, Silex Systems Limited, Mesoblast Limited, Clarity Pharmaceuticals Ltd and PYC Therapeutics Limited.